nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Creatinine increased—Vandetanib—thyroid cancer	0.0359	0.0408	CcSEcCtD
Fenoldopam—Myocardial ischaemia—Sorafenib—thyroid cancer	0.0286	0.0326	CcSEcCtD
Fenoldopam—Cardiac failure—Vandetanib—thyroid cancer	0.0254	0.0289	CcSEcCtD
Fenoldopam—Blood creatinine increased—Vandetanib—thyroid cancer	0.0232	0.0264	CcSEcCtD
Fenoldopam—Hypokalaemia—Vandetanib—thyroid cancer	0.0225	0.0257	CcSEcCtD
Fenoldopam—Urinary tract infection—Vandetanib—thyroid cancer	0.0186	0.0211	CcSEcCtD
Fenoldopam—Bradycardia—Vandetanib—thyroid cancer	0.0175	0.0199	CcSEcCtD
Fenoldopam—Haemoglobin—Vandetanib—thyroid cancer	0.0172	0.0196	CcSEcCtD
Fenoldopam—Haemorrhage—Vandetanib—thyroid cancer	0.0171	0.0195	CcSEcCtD
Fenoldopam—Cardiac failure—Sorafenib—thyroid cancer	0.0171	0.0195	CcSEcCtD
Fenoldopam—Lactic dehydrogenase activity increased—Epirubicin—thyroid cancer	0.0166	0.0189	CcSEcCtD
Fenoldopam—Lactic dehydrogenase activity increased—Doxorubicin—thyroid cancer	0.0154	0.0175	CcSEcCtD
Fenoldopam—Hypokalaemia—Sorafenib—thyroid cancer	0.0152	0.0173	CcSEcCtD
Fenoldopam—Blood lactate dehydrogenase increased—Epirubicin—thyroid cancer	0.0146	0.0167	CcSEcCtD
Fenoldopam—Muscle spasms—Vandetanib—thyroid cancer	0.0143	0.0163	CcSEcCtD
Fenoldopam—Transaminases increased—Epirubicin—thyroid cancer	0.014	0.0159	CcSEcCtD
Fenoldopam—Blood lactate dehydrogenase increased—Doxorubicin—thyroid cancer	0.0135	0.0154	CcSEcCtD
Fenoldopam—Transaminases increased—Doxorubicin—thyroid cancer	0.0129	0.0147	CcSEcCtD
Fenoldopam—Chest pain—Vandetanib—thyroid cancer	0.0127	0.0145	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Sorafenib—thyroid cancer	0.0127	0.0145	CcSEcCtD
Fenoldopam—Anxiety—Vandetanib—thyroid cancer	0.0127	0.0144	CcSEcCtD
Fenoldopam—Myocardial infarction—Sorafenib—thyroid cancer	0.0126	0.0144	CcSEcCtD
Fenoldopam—Haemoglobin—Sorafenib—thyroid cancer	0.0116	0.0132	CcSEcCtD
Fenoldopam—Haemorrhage—Sorafenib—thyroid cancer	0.0116	0.0132	CcSEcCtD
Fenoldopam—Insomnia—Vandetanib—thyroid cancer	0.011	0.0125	CcSEcCtD
Fenoldopam—Dyspnoea—Vandetanib—thyroid cancer	0.0109	0.0124	CcSEcCtD
Fenoldopam—Flushing—Sorafenib—thyroid cancer	0.0107	0.0122	CcSEcCtD
Fenoldopam—Constipation—Vandetanib—thyroid cancer	0.0104	0.0119	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00996	0.0113	CcSEcCtD
Fenoldopam—Muscle spasms—Sorafenib—thyroid cancer	0.00968	0.011	CcSEcCtD
Fenoldopam—Body temperature increased—Vandetanib—thyroid cancer	0.00963	0.011	CcSEcCtD
Fenoldopam—Abdominal pain—Vandetanib—thyroid cancer	0.00963	0.011	CcSEcCtD
Fenoldopam—Oliguria—Epirubicin—thyroid cancer	0.00923	0.0105	CcSEcCtD
Fenoldopam—Creatinine increased—Epirubicin—thyroid cancer	0.00894	0.0102	CcSEcCtD
Fenoldopam—Oliguria—Doxorubicin—thyroid cancer	0.00854	0.00973	CcSEcCtD
Fenoldopam—Injection site reaction—Epirubicin—thyroid cancer	0.00846	0.00963	CcSEcCtD
Fenoldopam—Diarrhoea—Vandetanib—thyroid cancer	0.00833	0.00949	CcSEcCtD
Fenoldopam—Creatinine increased—Doxorubicin—thyroid cancer	0.00827	0.00942	CcSEcCtD
Fenoldopam—Dizziness—Vandetanib—thyroid cancer	0.00805	0.00917	CcSEcCtD
Fenoldopam—Blood urea increased—Epirubicin—thyroid cancer	0.00803	0.00915	CcSEcCtD
Fenoldopam—Injection site reaction—Doxorubicin—thyroid cancer	0.00783	0.00891	CcSEcCtD
Fenoldopam—Vomiting—Vandetanib—thyroid cancer	0.00774	0.00882	CcSEcCtD
Fenoldopam—Headache—Vandetanib—thyroid cancer	0.00763	0.00869	CcSEcCtD
Fenoldopam—Blood urea increased—Doxorubicin—thyroid cancer	0.00743	0.00846	CcSEcCtD
Fenoldopam—Dyspnoea—Sorafenib—thyroid cancer	0.00732	0.00834	CcSEcCtD
Fenoldopam—Nausea—Vandetanib—thyroid cancer	0.00723	0.00824	CcSEcCtD
Fenoldopam—Constipation—Sorafenib—thyroid cancer	0.00702	0.008	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00672	0.00765	CcSEcCtD
Fenoldopam—Abdominal pain—Sorafenib—thyroid cancer	0.00649	0.00739	CcSEcCtD
Fenoldopam—Body temperature increased—Sorafenib—thyroid cancer	0.00649	0.00739	CcSEcCtD
Fenoldopam—Cardiac failure—Epirubicin—thyroid cancer	0.00633	0.00721	CcSEcCtD
Fenoldopam—Cardiac failure—Doxorubicin—thyroid cancer	0.00586	0.00667	CcSEcCtD
Fenoldopam—Blood creatinine increased—Epirubicin—thyroid cancer	0.00579	0.00659	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00564	0.00642	CcSEcCtD
Fenoldopam—Hypokalaemia—Epirubicin—thyroid cancer	0.00562	0.0064	CcSEcCtD
Fenoldopam—Diarrhoea—Sorafenib—thyroid cancer	0.00562	0.0064	CcSEcCtD
Fenoldopam—Dizziness—Sorafenib—thyroid cancer	0.00543	0.00618	CcSEcCtD
Fenoldopam—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00535	0.0061	CcSEcCtD
Fenoldopam—Vomiting—Sorafenib—thyroid cancer	0.00522	0.00595	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00522	0.00594	CcSEcCtD
Fenoldopam—Hypokalaemia—Doxorubicin—thyroid cancer	0.0052	0.00592	CcSEcCtD
Fenoldopam—Angina pectoris—Epirubicin—thyroid cancer	0.0052	0.00592	CcSEcCtD
Fenoldopam—Headache—Sorafenib—thyroid cancer	0.00515	0.00586	CcSEcCtD
Fenoldopam—Nausea—Sorafenib—thyroid cancer	0.00488	0.00556	CcSEcCtD
Fenoldopam—Angina pectoris—Doxorubicin—thyroid cancer	0.00481	0.00548	CcSEcCtD
Fenoldopam—Urinary tract infection—Epirubicin—thyroid cancer	0.00463	0.00527	CcSEcCtD
Fenoldopam—Sweating—Epirubicin—thyroid cancer	0.00456	0.0052	CcSEcCtD
Fenoldopam—Bradycardia—Epirubicin—thyroid cancer	0.00435	0.00495	CcSEcCtD
Fenoldopam—Haemoglobin—Epirubicin—thyroid cancer	0.00429	0.00489	CcSEcCtD
Fenoldopam—Urinary tract infection—Doxorubicin—thyroid cancer	0.00428	0.00487	CcSEcCtD
Fenoldopam—Haemorrhage—Epirubicin—thyroid cancer	0.00427	0.00487	CcSEcCtD
Fenoldopam—Sweating—Doxorubicin—thyroid cancer	0.00422	0.00481	CcSEcCtD
Fenoldopam—Bradycardia—Doxorubicin—thyroid cancer	0.00403	0.00458	CcSEcCtD
Fenoldopam—Haemoglobin—Doxorubicin—thyroid cancer	0.00397	0.00452	CcSEcCtD
Fenoldopam—Flushing—Epirubicin—thyroid cancer	0.00397	0.00452	CcSEcCtD
Fenoldopam—Haemorrhage—Doxorubicin—thyroid cancer	0.00395	0.0045	CcSEcCtD
Fenoldopam—Flushing—Doxorubicin—thyroid cancer	0.00367	0.00418	CcSEcCtD
Fenoldopam—Tension—Epirubicin—thyroid cancer	0.00365	0.00416	CcSEcCtD
Fenoldopam—Nervousness—Epirubicin—thyroid cancer	0.00361	0.00411	CcSEcCtD
Fenoldopam—Back pain—Epirubicin—thyroid cancer	0.0036	0.0041	CcSEcCtD
Fenoldopam—Muscle spasms—Epirubicin—thyroid cancer	0.00358	0.00407	CcSEcCtD
Fenoldopam—Tension—Doxorubicin—thyroid cancer	0.00338	0.00385	CcSEcCtD
Fenoldopam—Nervousness—Doxorubicin—thyroid cancer	0.00334	0.00381	CcSEcCtD
Fenoldopam—Back pain—Doxorubicin—thyroid cancer	0.00333	0.00379	CcSEcCtD
Fenoldopam—Muscle spasms—Doxorubicin—thyroid cancer	0.00331	0.00377	CcSEcCtD
Fenoldopam—Palpitations—Epirubicin—thyroid cancer	0.00329	0.00374	CcSEcCtD
Fenoldopam—Chest pain—Epirubicin—thyroid cancer	0.00317	0.00361	CcSEcCtD
Fenoldopam—Anxiety—Epirubicin—thyroid cancer	0.00316	0.00359	CcSEcCtD
Fenoldopam—Palpitations—Doxorubicin—thyroid cancer	0.00304	0.00346	CcSEcCtD
Fenoldopam—Tachycardia—Epirubicin—thyroid cancer	0.00296	0.00337	CcSEcCtD
Fenoldopam—Hyperhidrosis—Epirubicin—thyroid cancer	0.00293	0.00334	CcSEcCtD
Fenoldopam—Chest pain—Doxorubicin—thyroid cancer	0.00293	0.00334	CcSEcCtD
Fenoldopam—Anxiety—Doxorubicin—thyroid cancer	0.00292	0.00332	CcSEcCtD
Fenoldopam—Hypotension—Epirubicin—thyroid cancer	0.00284	0.00323	CcSEcCtD
Fenoldopam—Insomnia—Epirubicin—thyroid cancer	0.00275	0.00313	CcSEcCtD
Fenoldopam—Tachycardia—Doxorubicin—thyroid cancer	0.00274	0.00312	CcSEcCtD
Fenoldopam—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00272	0.00309	CcSEcCtD
Fenoldopam—Dyspnoea—Epirubicin—thyroid cancer	0.00271	0.00308	CcSEcCtD
Fenoldopam—Hypotension—Doxorubicin—thyroid cancer	0.00262	0.00299	CcSEcCtD
Fenoldopam—Constipation—Epirubicin—thyroid cancer	0.0026	0.00296	CcSEcCtD
Fenoldopam—Insomnia—Doxorubicin—thyroid cancer	0.00254	0.00289	CcSEcCtD
Fenoldopam—Dyspnoea—Doxorubicin—thyroid cancer	0.0025	0.00285	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00248	0.00283	CcSEcCtD
Fenoldopam—Constipation—Doxorubicin—thyroid cancer	0.0024	0.00273	CcSEcCtD
Fenoldopam—Body temperature increased—Epirubicin—thyroid cancer	0.0024	0.00273	CcSEcCtD
Fenoldopam—Abdominal pain—Epirubicin—thyroid cancer	0.0024	0.00273	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.0023	0.00262	CcSEcCtD
Fenoldopam—Body temperature increased—Doxorubicin—thyroid cancer	0.00222	0.00253	CcSEcCtD
Fenoldopam—Abdominal pain—Doxorubicin—thyroid cancer	0.00222	0.00253	CcSEcCtD
Fenoldopam—Diarrhoea—Epirubicin—thyroid cancer	0.00208	0.00236	CcSEcCtD
Fenoldopam—Dizziness—Epirubicin—thyroid cancer	0.00201	0.00229	CcSEcCtD
Fenoldopam—Vomiting—Epirubicin—thyroid cancer	0.00193	0.0022	CcSEcCtD
Fenoldopam—Diarrhoea—Doxorubicin—thyroid cancer	0.00192	0.00219	CcSEcCtD
Fenoldopam—Headache—Epirubicin—thyroid cancer	0.0019	0.00217	CcSEcCtD
Fenoldopam—Dizziness—Doxorubicin—thyroid cancer	0.00186	0.00211	CcSEcCtD
Fenoldopam—Nausea—Epirubicin—thyroid cancer	0.0018	0.00205	CcSEcCtD
Fenoldopam—Vomiting—Doxorubicin—thyroid cancer	0.00179	0.00203	CcSEcCtD
Fenoldopam—Headache—Doxorubicin—thyroid cancer	0.00176	0.002	CcSEcCtD
Fenoldopam—Nausea—Doxorubicin—thyroid cancer	0.00167	0.0019	CcSEcCtD
Fenoldopam—ADRA1D—Signaling Pathways—TSHR—thyroid cancer	0.00015	0.00123	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000149	0.00123	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—SST—thyroid cancer	0.000149	0.00122	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PRKAR1A—thyroid cancer	0.000148	0.00122	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PTCH1—thyroid cancer	0.000147	0.00121	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PRKAR1A—thyroid cancer	0.000147	0.00121	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—SST—thyroid cancer	0.000145	0.00119	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CALCA—thyroid cancer	0.000145	0.00119	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CDK1—thyroid cancer	0.000145	0.00119	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CALCA—thyroid cancer	0.000143	0.00118	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MEN1—thyroid cancer	0.000143	0.00117	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CDK1—thyroid cancer	0.000142	0.00117	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MEN1—thyroid cancer	0.000141	0.00116	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TCF7L1—thyroid cancer	0.00014	0.00115	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CALCA—thyroid cancer	0.00014	0.00115	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TSHR—thyroid cancer	0.000135	0.00111	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000135	0.00111	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—SST—thyroid cancer	0.000135	0.00111	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PRKAR1A—thyroid cancer	0.000133	0.00109	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—TP53—thyroid cancer	0.000131	0.00108	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CDK1—thyroid cancer	0.000131	0.00108	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CALCA—thyroid cancer	0.00013	0.00107	CbGpPWpGaD
Fenoldopam—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000129	0.00106	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PTCH1—thyroid cancer	0.000129	0.00106	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PTCH1—thyroid cancer	0.000127	0.00105	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MEN1—thyroid cancer	0.000127	0.00104	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CDK1—thyroid cancer	0.000126	0.00104	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TSHR—thyroid cancer	0.000126	0.00104	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TSHR—thyroid cancer	0.000124	0.00102	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PRKAR1A—thyroid cancer	0.000124	0.00102	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—NRG1—thyroid cancer	0.000124	0.00102	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—TPR—thyroid cancer	0.000123	0.00101	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PRKAR1A—thyroid cancer	0.000122	0.001	CbGpPWpGaD
Fenoldopam—ADRA2B—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000121	0.000997	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PRKAR1A—thyroid cancer	0.000121	0.000991	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MEN1—thyroid cancer	0.000119	0.000975	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SST—thyroid cancer	0.000118	0.000969	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CDK1—thyroid cancer	0.000118	0.000966	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MEN1—thyroid cancer	0.000117	0.000959	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SST—thyroid cancer	0.000116	0.000956	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PTCH1—thyroid cancer	0.000115	0.000944	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000115	0.000943	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TSHR—thyroid cancer	0.000114	0.000941	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CALCA—thyroid cancer	0.000113	0.000933	CbGpPWpGaD
Fenoldopam—ADRA2C—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000113	0.000932	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—SLC5A5—thyroid cancer	0.000113	0.000928	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000113	0.000926	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CALCA—thyroid cancer	0.000112	0.00092	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TERT—thyroid cancer	0.000111	0.000916	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TSHR—thyroid cancer	0.00011	0.000906	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PRKAR1A—thyroid cancer	0.000108	0.000892	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MEN1—thyroid cancer	0.000108	0.000885	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PTCH1—thyroid cancer	0.000107	0.000882	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HIF1A—thyroid cancer	0.000107	0.000876	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PTCH1—thyroid cancer	0.000106	0.000868	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SST—thyroid cancer	0.000105	0.000863	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MEN1—thyroid cancer	0.000104	0.000852	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CDK1—thyroid cancer	0.000103	0.000844	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TSHR—thyroid cancer	0.000102	0.000842	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CDK1—thyroid cancer	0.000101	0.000833	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CALCA—thyroid cancer	0.000101	0.000831	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PRKAR1A—thyroid cancer	0.000101	0.000829	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SST—thyroid cancer	9.81e-05	0.000806	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTCH1—thyroid cancer	9.73e-05	0.0008	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—NRAS—thyroid cancer	9.68e-05	0.000796	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SST—thyroid cancer	9.65e-05	0.000794	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MEN1—thyroid cancer	9.63e-05	0.000792	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—RXRA—thyroid cancer	9.49e-05	0.00078	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CALCA—thyroid cancer	9.44e-05	0.000776	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—NRAS—thyroid cancer	9.39e-05	0.000772	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTCH1—thyroid cancer	9.38e-05	0.000771	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CALCA—thyroid cancer	9.29e-05	0.000764	CbGpPWpGaD
Fenoldopam—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	9.2e-05	0.000757	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—SLC5A5—thyroid cancer	9.17e-05	0.000754	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDK1—thyroid cancer	9.15e-05	0.000752	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—NRAS—thyroid cancer	9.04e-05	0.000743	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SST—thyroid cancer	8.9e-05	0.000732	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—BRAF—thyroid cancer	8.82e-05	0.000725	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTCH1—thyroid cancer	8.71e-05	0.000716	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SST—thyroid cancer	8.57e-05	0.000705	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CALCA—thyroid cancer	8.57e-05	0.000704	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDK1—thyroid cancer	8.55e-05	0.000703	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDK1—thyroid cancer	8.41e-05	0.000691	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—KRAS—thyroid cancer	8.33e-05	0.000685	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CALCA—thyroid cancer	8.25e-05	0.000679	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NRG1—thyroid cancer	8.24e-05	0.000678	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NRG1—thyroid cancer	8.13e-05	0.000669	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—KRAS—thyroid cancer	8.08e-05	0.000664	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SST—thyroid cancer	7.97e-05	0.000655	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—KRAS—thyroid cancer	7.78e-05	0.00064	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDK1—thyroid cancer	7.75e-05	0.000637	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—RXRA—thyroid cancer	7.71e-05	0.000633	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	7.67e-05	0.00063	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	7.47e-05	0.000614	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TP53—thyroid cancer	7.41e-05	0.000609	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TERT—thyroid cancer	7.4e-05	0.000609	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—NRAS—thyroid cancer	7.34e-05	0.000604	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NRG1—thyroid cancer	7.34e-05	0.000604	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TERT—thyroid cancer	7.3e-05	0.0006	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—HRAS—thyroid cancer	7.08e-05	0.000582	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HIF1A—thyroid cancer	7.08e-05	0.000582	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HIF1A—thyroid cancer	6.98e-05	0.000574	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	6.94e-05	0.000571	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TP53—thyroid cancer	6.92e-05	0.000569	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—HRAS—thyroid cancer	6.87e-05	0.000565	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NRG1—thyroid cancer	6.86e-05	0.000564	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NRG1—thyroid cancer	6.75e-05	0.000555	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—AKT1—thyroid cancer	6.68e-05	0.000549	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—HRAS—thyroid cancer	6.62e-05	0.000544	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TERT—thyroid cancer	6.59e-05	0.000542	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CCND1—thyroid cancer	6.44e-05	0.000529	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—KRAS—thyroid cancer	6.32e-05	0.00052	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	6.31e-05	0.000518	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—AKT1—thyroid cancer	6.25e-05	0.000514	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—NRAS—thyroid cancer	6.24e-05	0.000513	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NRG1—thyroid cancer	6.22e-05	0.000512	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PTEN—thyroid cancer	6.22e-05	0.000511	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TERT—thyroid cancer	6.16e-05	0.000506	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—NRAS—thyroid cancer	6.15e-05	0.000506	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—AKT1—thyroid cancer	6.06e-05	0.000498	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TERT—thyroid cancer	6.06e-05	0.000498	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	6e-05	0.000493	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PPARG—thyroid cancer	5.99e-05	0.000492	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	5.89e-05	0.000484	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—BRAF—thyroid cancer	5.86e-05	0.000482	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—AKT1—thyroid cancer	5.84e-05	0.00048	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	5.8e-05	0.000477	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—BRAF—thyroid cancer	5.78e-05	0.000475	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TP53—thyroid cancer	5.62e-05	0.000462	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TERT—thyroid cancer	5.59e-05	0.000459	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	5.57e-05	0.000458	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	5.56e-05	0.000457	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—NRAS—thyroid cancer	5.54e-05	0.000456	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TERT—thyroid cancer	5.38e-05	0.000443	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—HRAS—thyroid cancer	5.37e-05	0.000442	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—KRAS—thyroid cancer	5.37e-05	0.000441	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HIF1A—thyroid cancer	5.34e-05	0.000439	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—KRAS—thyroid cancer	5.3e-05	0.000435	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	5.22e-05	0.000429	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	5.19e-05	0.000427	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	5.15e-05	0.000423	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	5.11e-05	0.00042	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TERT—thyroid cancer	5e-05	0.000411	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	4.88e-05	0.000401	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PPARG—thyroid cancer	4.87e-05	0.0004	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	4.8e-05	0.000395	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	4.78e-05	0.000393	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	4.78e-05	0.000393	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—KRAS—thyroid cancer	4.77e-05	0.000392	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—AKT1—thyroid cancer	4.74e-05	0.00039	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—thyroid cancer	4.71e-05	0.000387	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—NRAS—thyroid cancer	4.71e-05	0.000387	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—HRAS—thyroid cancer	4.56e-05	0.000375	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	4.54e-05	0.000373	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	4.5e-05	0.00037	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	4.47e-05	0.000367	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	4.44e-05	0.000365	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—BRAF—thyroid cancer	4.43e-05	0.000364	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	4.4e-05	0.000361	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	4.38e-05	0.00036	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCND1—thyroid cancer	4.28e-05	0.000352	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	4.26e-05	0.000351	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—thyroid cancer	4.24e-05	0.000349	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	4.22e-05	0.000347	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	4.22e-05	0.000347	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PTEN—thyroid cancer	4.13e-05	0.000339	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTEN—thyroid cancer	4.11e-05	0.000338	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	4.07e-05	0.000335	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	4.06e-05	0.000334	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HRAS—thyroid cancer	4.06e-05	0.000333	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—KRAS—thyroid cancer	4.05e-05	0.000333	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—thyroid cancer	4.03e-05	0.000331	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	3.97e-05	0.000327	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	3.96e-05	0.000326	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	3.95e-05	0.000325	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	3.9e-05	0.000321	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—thyroid cancer	3.83e-05	0.000315	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	3.81e-05	0.000313	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	3.8e-05	0.000312	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	3.74e-05	0.000307	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	3.69e-05	0.000303	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NRAS—thyroid cancer	3.68e-05	0.000303	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	3.68e-05	0.000302	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	3.64e-05	0.000299	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	3.63e-05	0.000299	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	3.63e-05	0.000298	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	3.59e-05	0.000295	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—thyroid cancer	3.58e-05	0.000294	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	3.56e-05	0.000293	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	3.5e-05	0.000288	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HRAS—thyroid cancer	3.44e-05	0.000283	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	3.44e-05	0.000282	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	3.38e-05	0.000278	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	3.35e-05	0.000276	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	3.35e-05	0.000275	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTEN—thyroid cancer	3.34e-05	0.000274	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	3.32e-05	0.000273	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	3.3e-05	0.000271	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	3.28e-05	0.00027	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCND1—thyroid cancer	3.23e-05	0.000266	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	3.23e-05	0.000265	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KRAS—thyroid cancer	3.17e-05	0.000261	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	3.13e-05	0.000257	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTEN—thyroid cancer	3.12e-05	0.000256	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	3.11e-05	0.000256	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	3.08e-05	0.000253	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	3.07e-05	0.000252	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—thyroid cancer	3.04e-05	0.00025	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	3.02e-05	0.000248	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	3e-05	0.000247	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	3e-05	0.000246	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	2.93e-05	0.000241	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	2.89e-05	0.000238	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	2.82e-05	0.000232	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—thyroid cancer	2.82e-05	0.000232	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	2.79e-05	0.000229	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NRAS—thyroid cancer	2.78e-05	0.000229	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—thyroid cancer	2.78e-05	0.000229	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	2.72e-05	0.000224	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HRAS—thyroid cancer	2.7e-05	0.000222	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	2.68e-05	0.00022	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	2.66e-05	0.000219	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	2.64e-05	0.000217	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	2.6e-05	0.000213	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—thyroid cancer	2.51e-05	0.000206	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	2.49e-05	0.000205	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	2.4e-05	0.000197	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KRAS—thyroid cancer	2.39e-05	0.000197	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—thyroid cancer	2.38e-05	0.000196	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—thyroid cancer	2.37e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	2.35e-05	0.000193	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—thyroid cancer	2.35e-05	0.000193	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—thyroid cancer	2.31e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	2.31e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	2.24e-05	0.000184	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	2.21e-05	0.000181	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	2.14e-05	0.000176	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—thyroid cancer	2.13e-05	0.000175	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	2.12e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—thyroid cancer	2.05e-05	0.000169	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HRAS—thyroid cancer	2.03e-05	0.000167	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	1.98e-05	0.000163	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	1.96e-05	0.000161	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	1.95e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—thyroid cancer	1.92e-05	0.000158	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—thyroid cancer	1.9e-05	0.000157	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	1.82e-05	0.00015	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—thyroid cancer	1.8e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	1.73e-05	0.000142	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	1.61e-05	0.000132	CbGpPWpGaD
